Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US0028241000
Ticker ABT
Company ABBOTT LABORATORIES
Currency $
Price
Aware Investor Index (AII) 0.3603
Recommendation HOLD
P/E 39.90
ROE 11.33 %
Capitalization 138,006,900,000 $
Dividend Yield 1.49 %
P/S 4.51
AII Position 364
P/E Position 547
ROE Position 334
Capitalization Position 57
Dividend Yield Position 466
Sales 30,578,000,000 $
10-Year Average Earnings 3,459,140,000 $
Shares Outstanding 1,770,000,000
Equity 30,524,000,000 $
Dividend per Share 1.16 $
Industry Pharmaceutical
Country United States
ABBOTT LABORATORIES Investor Relations Web Site http://www.abbottinvestor.com







Sales:

YEAR MONTH AMOUNT
2018 12 30,578,000,000.00 $
2017 12 27,390,000,000.00 $
2016 12 20,853,000,000.00 $
2015 12 20,405,000,000.00 $
2014 12 20,247,000,000.00 $
2013 12 19,657,000,000.00 $
2012 12 19,050,000,000.00 $
2011 12 18,663,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 2,368,000,000.00 $
2017 12 477,000,000.00 $
2016 12 1,400,000,000.00 $
2015 12 4,423,000,000.00 $
2014 12 2,284,000,000.00 $
2013 12 2,576,000,000.00 $
2012 12 5,963,000,000.00 $
2011 12 4,728,400,000.00 $
2010 12 4,626,200,000.00 $
2009 12 5,745,800,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 30,524,000,000.00 $
2017 12 30,897,000,000.00 $
2016 12 20,717,000,000.00 $
2015 12 21,326,000,000.00 $
2014 12 21,639,000,000.00 $
2013 12 25,267,000,000.00 $
2012 12 26,813,232,000.00 $
2011 12 24,526,145,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 1,770,000,000
2017 12 1,749,000,000
2016 12 1,483,000,000
2015 12 1,506,000,000
2014 12 1,527,000,000
2013 12 1,574,000,000
2012 12 1,592,000,000
2011 12 1,567,389,000

 












Bloomberg News for ABBOTT LABORATORIES:



Google News for ABBOTT LABORATORIES:

US Post News - 1 hour ago
Let's Take a Fresh Look at Abbott Laboratories (ABT)
BofA/Merrill equity researchers changed the status of Abbott Laboratories (NYSE: ABT) shares to a “Buy” rating in the report published on ...
FinBulletin
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Abbott ...
While Shares of Abbott Laboratories (NYSE: ABT) constructed a change of 0.33% (Gain, ↑) and closed at $78.23. Alexion Pharmaceuticals ...
News Room Alert (press release)
Shares Under Review: Abbott Laboratories (NYSE:ABT): 20 Day ...
Once the individual investor has figured out a plan to analyze stocks, they can begin to start building a portfolio. Because not everyone has the ...
Nyse Nasdaq News (press release)
Abbott Laboratories [ABT] – How low can NYSE:ABT go? A return to ...
Stock traders often pay close attention what Wall Street analysts have to say about a potential investment. For Abbott Laboratories [ABT], the ...
News Parents (press release) - 1 hour ago
Abbott Laboratories (ABT) Is Slightly : Here is Why ABT Stock is Still ...
At the moment, the debt-to-equity of Abbott Laboratories (NYSE:ABT) is high, standing at 64.10, a figure that is higher than the 36.46 average ...
Weston Business Review - 5 hours ago
Shares of Abbott Laboratories (ABT) See Mesa Average Hold Above ...
Shares of Abbott Laboratories (ABT) have seen the Mesa Adaptive Moving Average (MAMA) climb above the Fractional Moving Average or ...
The Dwinnex - 3 days ago
$0.61 EPS Expected for Abbott Laboratories (ABT); 1 Bullish ...
Analysts expect Abbott Laboratories (NYSE:ABT) to report $0.61 EPS on April, 17.They anticipate $0.02 EPS change or 3.39% from last ...
FinBulletin
Is It Right Time to Be Bearish on Abbott Laboratories (ABT), Intrexon ...
The shares of Abbott Laboratories (NYSE:ABT) has been pegged with a rating of Buy by BofA/Merrill in its latest research note that was ...
MONReport
Abbott Laboratories (NYSE:ABT) Needle Ticks -0.76% For the Week
Abbott Laboratories (NYSE:ABT) shares have moved -0.76% on the week. The stock closed the most recent session at $78.23 after seeing ...
News Parents (press release)
The Media Is Not Focusing Enough On Arista Networks, Inc. (ANET ...
Switching to Abbott Laboratories (NYSE:ABT), ABT shares traded at the value of $79.94 after a gain of $23.25 during the latest trading session.


Back